The landscape of rare genetic disorders has been revolutionized by advances in understanding and treating Mucopolysaccharidosis (MPS) conditions. These inherited lysosomal storage diseases affect thousands of individuals worldwide, presenting complex clinical challenges that require specialized expertise and multidisciplinary care approaches. The accumulation of glycosaminoglycans in...

  Modern medicine stands at the threshold of a computational renaissance, where biological complexity meets algorithmic sophistication to unlock unprecedented therapeutic possibilities. As healthcare systems confront rising costs and limited treatment options for complex diseases, generative AI in pharma emerges as the cornerstone of a new therapeutic paradigm, fundamentally altering our...